(ULB-VUB), Brussels SUMMARY Fourteen patients with classical and definite seropositive rheumatoid arthritis (RA), 5 patients with microcrystalline arthritis, and 7 patients with osteoarthrosis were studied with respect to markers of newly synthesised collagen (synovial NDOH pro levels); markers of connective tissue resorption (synovial DOH pro and NBH levels); markers of lymphoid tissue activity (synovial and plasma P2m levels). Higher amounts of NDOH pro in RA synovial fluid are compatible with the hypothesis of a local connective tissue production as suggested by Uitto et al. on basis of a higher protocollagen proline hydroxylase activity in RA synovial tissue. DOH pro and NBH do not differ significantly in synovial fluid from RA or gouty patients, but the correlations between these forms of OH pro and, respectively, synovial lymphocytes and polymorphonuclear leucocytes are indicative of different processes of connective tissue remodelling in the 2 conditions. Synovial P2m levels are a direct function of total synovial lymphocyte counts independently of the type of arthropathy being explored. The ratio of synovial to plasma r32m is systematically above unity in RA patients only.
Recent work on 32 microglobulin (f2m) led to the discovery of its immunogenetic aspect, though its exact function in this respect is still unknown (Marx, 1974) . This 11 700 molecular weight (MW) protein has a close homology with the constant domains of the heavy and light chains of immunoglobulins, especially with the CH3 domain (Berggard and Bearn, 1968; Peterson et al., 1972; Smithies and Poulik, 1972; Cunningham et al., 1973). P2m is normally present in low concentrations in serum and generally speaking in all biological fluids (Evrin et al., 1971; Evrin and Wibell, 1972) .
The circulating 32m, however, does not derive from a splitting of immunoglobulins, and its production does not depend only on B cell function (Cejka et al., 1973; Hutteroth et al., 1973; Nilson et al., 1973) . P2m is a part of the major histocompatibility cell-membrane-bound antigenic complexes (Cresswell et al., 1973; Grey et al., 1973; Nakamuro et al., 1973; Cresswell et al., 1974; Peterson et al., 1974 Tanigaki and Pressman, 1974) and is produced by lymphocytes (T and B) and cell lines of tumoral or nontumoral lymphoid tissues (Bernier and Fanger, 1972; Hutteroth et al., 1973; Nilson et al., 1973; Poulik and Bloom, 1973; Kithier et al., 1974; Nilson et al., 1974) .
Except for cases of renal insufficiency or pregnancy, increased serum levels of r2m were reported in patients with advanced malignant disease and in come inflammatory autoimmune disorders such as ulcerative colitis, regional enteritis, systemic lupus erythematosus (SLE) dysglobulinaemic purpura, and rheumatoid arthritis (RA) (Evrin and Wibell, 1973; Brauman et al., 1977) . Talal et al. (1975) reported elevated concentrations of P2m in saliva and synovial fluid from patients with Sjogren's syndrome. In patients with RA we described increased circulating f2m paralleling the lymphocytosis and reflecting the severity and extension of the joint involvement as well as the onset of extra-articular involvement (Manicourt et al., 1978 ). An intense subsynovial lymphocytic and inflammatory cell infiltration characterises the RA joint cavity (Talal, 1972) , and an increased collagenase production by this hypercellular rheumatoid synovial tissue may be an 207 important cause of joint destruction (Evanson et al., Among the different OH pro fractions dialysable 1968; Harris et al., 1969; Wegelius et al., 1970) .
OH pro (DOH pro) and mainly nonprotein bound Hydroxyproline (OH pro) was described as a OH pro (NBH) appear to be relevant markers of bone metabolic marker of the collagen whose biosynthesis collagen disorders and especially of bone resorption is increased in RA synovial tissue (Uitto et al., 1972) . (Kivirikko, 1970; Krane et al., 1970; Bishop and or from fragments recently synthesised but not incorporated into tropocollagen (Krane et al., 1967 (Krane et al., , 1970 Haddad et al., 1970) .
As P2m production is associated with lymphocytes it was of interest to study the levels of r32m in the synovial fluid of patients suffering from RA and to correlate these data with the synovial cytology, the synovial total and different OH pro fractions, and the degree of disease activity as expressed by the joint count (Hollander and McCarty, 1972) , the erythrocyte sedimentation rate (ESR), the serum latex fixation test (LF), and the plasma f32m levels (Manicourt et al., 1978 were measured in hydrolysed and unhydrolysed samples (Delfosse et al., 1975) ; the nondialysable fraction (NDOH pro) was isolated (Haddad et al., 1970) Tables 1 and  2 , they were obtained from various joint cavities.
Results
The relevant biological data are presented in Table 1 and 2.
Synovial 32m levels are highest in RA patients (group A) and differ significantly between the 3 groups (P<0-001) (Fig. 1) . Total OH pro levels for groups A and B (Fig. 1 ) are significantly higher when compared to group C (P<0 *001); no statistical difference is found between groups A and B (P<0. 1). The NDOH pro values (Fig. 1) in group A are significantly higher than those observed in group B (P<0-001) whereas there is no statistical difference between the DOH pro and the NBH values in these 2 different groups (Fig. 1) ficant positive linear correlation is found between the synovial r2m levels and the synovial lymphocytosis (Fig. 2) . In RA patients (group A) measurements of overall disease activity (JC, plasma 32m levels, ESR, and LF) show a positive correlation with synovial r.m levels (Figs. 3 and 4) . Moreover, in the same patients (group A) the synovial F2m values correlate significantly with the synovial total OH pro (r=0-70; P<0001), with the synovial DOH pro (r=083; P<0O001) and with the synovial NBH (r=0-81; P<0-001) (Fig. 5) . As might be expected from the data in Fig. 2 (Fig. 6 ). No such correlations were found in control groups. Interestingly enough, in gouty patients (group B) the synovial OH pro fractions are correlated with the synovial polymorphonuclear neutrophil (PMN) count (Fig. 7) and not with the synovial lymphocyte count.
In none of the groups studied is there any correlation between synovial NDOH pro levels and synovial cells count (PMN or lymphocytes).
It is further noted that in each RA patient synovial P2m levels are systematically higher than plasma P2m levels in contrast to the 2 other groups (Tables   1 and 2 ).
Discussion
From our results it emerges that synovial fluid NDOH pro is significantly higher in RA than in gouty patients and that no correlation exists between this fraction and the cellular content of the synovial fluid. Since NDOH pro is said to originate from fragments recently synthesised but not incorporated into tropocollagen (Krane et al., 1967 (Krane et al., , 1970 Haddad et al., 1970) , a higher content of this fraction could be evidence of a higher rate of collagen biosynthesis, which agrees with a protocollagen proline hydroxylase hyperactivity in RA synovial tissue (Uitto et al., 1972 Bunch et al., 1974; Williams, 1976) suggest that NDOH pro in RA reflects rather connective tissue activation. This conclusion would hold unless it can be shown that the low levels described in synovial fluid are not only due to a high consumption rate but to a turnover that is fast enough to produce more NDOH pro in RA than in gout but also specific enough to stop at this stage, since total OH pro appears to be identical in synovial fluid of both conditions. (McCarty et al., 1962; Weissmann, 1966 Weissmann, , 1967 Weissmann, , 1972 McCarty, 1971; Wright and Malawista, 1973) . In contrast the positive correlation between lymphocyte count and DOH pro or NBH levels in synovial fluid from RA patients (Fig. 6) (Woolley et al., 1977) . Moreover, macrophages incubated with lymphokines can product collagenase (Wahl et al., 1975) , and Dayer et al. (1977) have recently reported that lymphocytes produce a low molecular weight factor (MW 11 500) stimulating collagenase production by rheumatoid synovial cells in culture.
Our observation that synovial P2m levels are a direct function of synovial lymphocyte count irrespective of the joint pathology (Fig. 2) is not surprising since the lymphoid tissue is well known to be a major source of P2m (Bernier and Fanger, 1972) . Synovial P2m overproduction (Tables 1 and 2) and the correlation between markers of bone collagen resorption (namely, DOH pro and NBI{) and synovial r2m levels on the one hand (Fig. 5) and synovial lymphocyte count on the other (Fig. 6 ) are observed only in RA patients whose overall disease activity is already shown to correlate with synovial ,32m levels (Figs. 3 and 4) . These data appear as an in-vivo confirmation of Dayer et al.'s in-vitro observation of the stimulating effect of lymphocytes on collagenase production (Dayer et al., 1977) . Synovial r2m can be thus considered as a fair index of synovial lymphoid tissue overactivity in RA and of the severity of RA joint involvement and destructive potential. Since 32m has no known function per se (either as an enzyme or as a stimulator), and in absence of further characterisation of the low molecular weight (MW 11 500) factor described by Dayer et al. (1977) , it is at best to consider them as special evidence of lymphoid cells activity in RA. This is further substantiated by the observation that the synovial to plasma 2m ratio is systematically raised above unity in only RA in contrast to nonautoimmune arthropathies (microcrystalline arthritis or osteoarthrosis), where it is systematically lower than unity, an observation that could eventually be useful in differentiating both conditions. This work was supported by a grant from the National Bank of Belgium to the Rheumatology Laboratory (ULB-VUB).
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